Search
+
    SEARCHED FOR:

    RAMESH DAMANI

    Damani, Madhu Kela join Ranbir Kapoor to back this smallcap; acquire stake via bulk deals. Shares surge 10%

    Prime Focus attracted significant investments from market veterans like Ramesh Damani, Singularity AMC, and Utpal Sheth, leading its shares to surge by 10% on the BSE. These investors collectively acquired a 3.3% stake, amounting to approximately Rs 146.2 crore.

    NCDEX unlisted shares rocket 14% as Radhakishan Damani, Madhu Kela, Zerodha, Groww commit crores

    NCDEX unlisted shares surged 14.5% to Rs 475 after raising Rs 770 crore from top investors, including Radhakishan Damani, Zerodha, and Groww, ahead of its 2026 equity segment launch. The funding supports expansion into cash equities and derivatives, leveraging its rural commodities network amid rising competition.

    Radhakishan Damani, Ramesh Damani, Madhu Kela, Zerodha, Groww line up to invest crores in NCDEX

    NCDEX raised Rs 770 crore from star investors like Radhakishan Damani, Madhusudhan Kela, Sunil Singhania, Groww, and Zerodha after Sebi’s nod for equities. It plans to launch equity trading in 2026, competing with NSE and BSE.

    Protean eGov crashes 50% from peak. Should you hold or exit this Ramesh Damani stock?

    Protean eGov Technologies, backed by Ramesh Damani, has seen its stock price plummet nearly 50% from its 52-week high. Analysts attribute the decline to the company's failure to secure the government's PAN 2.0 project. Despite a minor technical bounce, experts advise caution, citing a weak technical structure and the formation of lower highs and lows.

    Ramesh Damani to meet MSTC management on Dec 9, shares jump 6%

    MTSC, with the government holding a 64.75% stake, offers e-commerce services across various segments.

    Best multibagger idea is to remain invested in India; stick to PSUs but not the same shares: Ramesh Damani

    Ramesh Damani is optimistic about the Indian market's long-term prospects despite current volatility. He suggests focusing on digital public infrastructure and select pharmaceutical stocks. Damani advises staying invested in India, noting that the market has historically shown resilience and growth. He highlights the importance of distinguishing between risk and volatility for long-term investors.

    The Economic Times
    BACK TO TOP